Jan Dominik Kuhlmann

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Cross Sectional

Tyrosine Kinase

Breast Cancer Cells

Top Venues

Molecular oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical chemistry and laboratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, Kati Schuster, Mirko Theis, Alexander Krüger, Oliver Kutz, Theresa Link, Pauline Wimberger, Stephan Drukewitz, Frank Buchholz, Jürgen Thomale, Jan Dominik Kuhlmann
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer. Cancers 15 (15) (2023)
Theresa Link, Jens-Uwe Blohmer, Wolfgang Daniel Schmitt, Jan Dominik Kuhlmann, Marianne Just, Michael Untch, Oliver Stotzer, Peter Andreas Fasching, Marc Thill, Mattea Reinisch, Andreas Schneeweiß, Pauline Wimberger, Sabine Seiler, Jens Huober, Christian Jackisch, Kerstin Rhiem, Claus Hanusch, Bruno Valentin Sinn, Valentina Nekljudova, Sibylle Loibl, Carsten Denkert
RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lila Bemmerlein, Ilker A Deniz, Jana Karbanová, Angela Jacobi, Stephan Drukewitz, Theresa Link, Andy Göbel, Lisa Sevenich, Anna Verena Taubenberger, Pauline Wimberger, Jan Dominik Kuhlmann, Denis Corbeil
Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical Heterogeneity. Cancers 14 (3) (2022)
Hagen Sjard Bachmann, Dominik Jung, Theresa Link, Anna Arnold, Eva Kantelhardt, Christoph Thomssen, Pauline Wimberger, Martina Vetter, Jan Dominik Kuhlmann
FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer. Cancers 14 (3) (2022)
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Fuessel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars C Hanker, Jan Dominik Kuhlmann
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Daniel Martin Klotz, Theresa Link, Maren Goeckenjan, Pauline Wimberger, Jan Dominik Kuhlmann
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker. Molecular oncology 15 (9) (2021)
Daniel Martin Klotz, Theresa Link, Pauline Wimberger, Jan Dominik Kuhlmann
Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer. Molecular oncology 15 (12) (2021)
Daniel Martin Klotz, Theresa Link, Maren Goeckenjan, Pauline Wimberger, Anna R Poetsch, Nikolai Jaschke, Lorenz C Hofbauer, Andy Göbel, Tilman D Rachner, Jan Dominik Kuhlmann
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients. Clinical chemistry and laboratory medicine 60 (1) (2021)
Margarita Melnikova, Ulrike Sophie Wauer, Diana Mendus, Ralf Axel Hilger, Trudy G Oliver, Kim Mercer, Björn Oliver Gohlke, Kati Erdmann, Dieter Niederacher, Hans Neubauer, Paul Buderath, Pauline Wimberger, Jan Dominik Kuhlmann, Juergen Thomale
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Molecular oncology 14 (4) (2020)
Theresa Link, Simon Passek, Pauline Wimberger, Kerstin Frank, Yana Damyanova Vassileva, Michael Kramer, Jan Dominik Kuhlmann
Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer. International journal of cancer 146 (9) (2019)